Key result
An abnormal high-sensitivity cardiac troponin T value (>0.014 ng/mL) was an independent predictor of cardiac events in patients with dilated cardiomyopathy (HR 5.68).
Why the study?
Does an abnormal high-sensitivity cardiac troponin T (hs-cTnT) level predict adverse cardiac events in patients with clinically stable dilated cardiomyopathy?
Cohort (n=54)
No
Does an abnormal high-sensitivity cardiac troponin T (hs-cTnT) level predict adverse cardiac events in patients with clinically stable dilated cardiomyopathy?
Hazard Ratio: 5.68 (95% CI 1.78–18.18)
p-value: p=0.003
In patients with stable dilated cardiomyopathy, an elevated high-sensitivity cardiac troponin T (hs-cTnT) level is a strong, independent predictor of adverse cardiac events and lack of reverse remodeling.
No takes yet. Share an insight, caveat, or question.
May refine prognosis in stable dilated cardiomyopathy; extends observational data but requires prospective validation before guiding care.
Baba et al. (2015) conducted a cohort in Dilated Cardiomyopathy (n=54). Abnormal high-sensitivity cardiac troponin T (> 0.014 ng/mL) vs. Normal high-sensitivity cardiac troponin T (≤ 0.014 ng/mL) was evaluated on Composite of heart failure deaths, sudden cardiac deaths, and hospitalization for heart failure (HR 5.68, 95% CI 1.78-18.18, p=0.003). An abnormal high-sensitivity cardiac troponin T value (>0.014 ng/mL) was an independent predictor of cardiac events in patients with dilated cardiomyopathy (HR 5.68).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: